13F filing recap · Q2 2008

What did Cantillon Capital Management buy in Q2 2008?

Reported stock-position changes between this filing and the previous one.

Stock value

$3.24B

Positions

Estimated turnover

70.1%

Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.

New positions

HNZH.j. Heinz Company$182.34Mreported value+3.81M shares USTUst Inc$109.98Mreported value+2.01M shares DLTRDollar Tree, Inc.$88.07Mreported value+2.69M shares UNUnilever Plc$19.37Mreported value+682.0K shares EEni Spa$17.07Mreported value+230.0K shares AAUKYAnglo American Plc$16.53Mreported value+466.3K shares VDSIVasco Data Security International Inc$8.07Mreported value+766.0K shares COHCoach Inc$6.73Mreported value+233.0K shares ULUnilever Plc$5.94Mreported value+209.0K shares ANFAbercrombie & Fitch Co.$4.70Mreported value+75.0K shares SNNSmith & Nephew Plc$2.26Mreported value+41.3K shares

Increased positions

KRKroger Co$275.82Mreported value+1.01M shares+11.8%MSFTMicrosoft Corporation$266.91Mreported value+227.0K shares+2.4%PBR.APetrobras - Petroleo Brasileiro SA$253.87Mreported value+2.91M shares+197.1%AAAlcoa Corp$229.89Mreported value+148.0K shares

Reduced positions

PEPPepsico, Inc.$206.59Mreported value-320.3K shares-9.0%MDTMedtronic Plc$188.71Mreported value-12.0K shares-0.3%PGProcter & Gamble Co$147.90Mreported value-1.59M shares-39.5%COVCovidien Ltd$128.75Mreported value-960.0K shares

Exited positions

TEVATeva Pharmaceutical Industries Limited$238.24Mprior reported value-5.16M shares-100.0%BRLBarr Pharmaceuticals Inc.$176.92Mprior reported value-3.66M shares-100.0%WLPWellpoint Inc$122.04Mprior reported value-2.77M shares-100.0%HLFHerbalife Ltd.$91.41Mprior reported value